MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Temporal characterization of motor, gastrointestinal, and behavioral symptoms in a SNCA A53T transgenic mouse model of Parkinson’s disease

    N. Radisavljevic, M. Cirstea, K. Bauer, B. Finlay (Vancouver, BC, Canada)

    Objective: While multiple animal models of Parkinson’s disease (PD) have been developed with varying applicability to different aspects of the disorder, no single model effectively…
  • MDS Virtual Congress 2020

    Diagnostic value of olfactory dysfunction in Parkinson’s disease

    K. Stepanchenko, V. Marchenko, A. Zhidkova (Kharkiv, Ukraine)

    Objective: To assess the olfactory performance in patients with PD using “Sniffin’ Sticks”. Background: Olfactory dysfunction is an important early premotor biomarker for PD, and…
  • MDS Virtual Congress 2020

    Olfactory dysfunction and its relationship with clinical features of Parkinson’s disease

    Y.J Zhou, R.C He, Y.W Zhao, XX. Yan, B.S Tang, J.F Guo (Changsha, China)

    Objective: To investigate the reliability of assessing olfactory function of patients with PD by HRS in China and compare other non-motor features between patients with PD…
  • MDS Virtual Congress 2020

    Sensorimotor inhibition relates to gait dysfunction in people with Parkinson’s disease

    D. Martini, G. Harker, R. Morris, J. Nutt, F. Horak (Portland, OR, USA)

    Objective: To determine how sensorimotor inhibition relates to objective measures of gait OFF and ON levodopa and how having Parkinson’s disease (PD) affects this relationship.…
  • MDS Virtual Congress 2020

    Increased epinephrine in the saliva of Parkinson’s disease patients: A preliminary observation

    P. Wichit, S. Thanprasertsuk, T. Hopetrungraung, O. Phokaewvarangkul, S. Bongsebandhu-phubhakdi, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To investigate the levels of dopamine (DA), norepinephrine (NE), epinephrine (EPI) and serotonin (5-HT) in the saliva of Parkinson’s disease (PD) patients and compare…
  • MDS Virtual Congress 2020

    Association between impulse control disorders and depression in drug-naïve Parkinson’s disease

    A. Karukote, S. Thakolwiboon, P. Julayanont (Lubbock, TX, USA)

    Objective: To determine the association between depression and impulse control disorders (ICDs) in patients with Parkinson's disease (PD). Background: Depression is one of the most…
  • MDS Virtual Congress 2020

    WATCH-PD: Wearable Assessments in the Clinic and Home in Parkinson’s Disease: Study Design and Update

    J.L Adams, E.R Dorsey, A. Steinman, T. Kangarloo, R. Alexander, B. Tracey, N. Zach, R. Rubens, M. Kostrzebski, M. Bockus, R. O'Loughlin, E.A Stevenson, J. Cosman (Rochester, NY, USA)

    Objective: To determine whether digital measures can provide a progression profile in early Parkinson’s disease (PD) that is more sensitive and/or less variable than current…
  • MDS Virtual Congress 2020

    MOve To ImprovE physical activity in Parkinson’s disease (MOTIvatE): A pilot randomized clinical trial of gamification

    N. Dahodwala, M. Engeland, W. Kerr, L. Walsh, M. Patel (Philadelphia, PA, USA)

    Objective: To test the feasibility and impact of a behaviorally designed gamification intervention to improve goal-directed behavior assessed by physical activity levels in Parkinson’s disease…
  • MDS Virtual Congress 2020

    Safety and Tolerability of Burst Cycling Deep Brain Stimulation for Freezing of Gait in Parkinson’s Disease

    W. Hu, J. Wang, R. Barmore, J. Melo Lobo, T. Tsuboi, A. Wang, A. Ramirez-Zamora, M. Okun, L. Almeida (Gainesville, FL, USA)

    Objective: To determine the safety and tolerability of burst cycling deep brain stimulation (DBS) in Parkinson's disease (PD) patients experiencing freezing of gait (FoG). Background:…
  • MDS Virtual Congress 2020

    Application of PKG System for Objective Measurement and Early Identification in Parkinson’s Disease

    C. Lina, C. Guoen, W. Huidan, W. Yingqing, C. Ying, C. Xiaochun, Y. Qinyong (Fuzhou, China)

    Objective: This study aimed to assess the correlations of the PKG data with clinical scores of bradykinesia, rigidity and tremor. Background: The treatment of levodopa…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 149
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley